GPT Healthcare Limited has submitted a regulatory disclosure to BSE Limited and the National Stock Exchange of India Limited intimating them of a scheduled meeting with analysts and institutional investors.
The disclosure is made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meeting Details
- Date: Thursday, June 11, 2026
- Event: InsightX 2026 - Choice Virtual Conference
- Participants: Institutional Investors and Fund managers
- Format: Virtual (Group Meeting)
- Time: 3:00 PM IST
Key Disclosures and Disclaimers
The company explicitly states that no Unpublished Price Sensitive Information (UPSI) will be shared during this meeting.
The material for discussion will be the company's Investor Presentation for Q4 FY26 (March 2026), which is stated to already be in the public domain and available on the company's website and the stock exchanges' websites.
The letter notes that changes to the schedule may occur due to exigencies on the part of the investors, analysts, or the company itself.